Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria (Q34269828)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria |
scientific article |
Statements
1 reference
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria (English)
1 reference
Satish Garg
1 reference
Ann Marie Ocampo Francisco
1 reference
Areti Philotheou
1 reference
Miles Fisher
1 reference
Ludwig Merker
1 reference
Eric Renard
1 reference
David Russell-Jones
1 reference
Huiling Pei
1 reference
Bruce Bode
1 reference
BEGIN Basal-Bolus Type 1 Trial Investigators
1 reference
Identifiers
1 reference